These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

369 related articles for article (PubMed ID: 32759064)

  • 1. Vagus nerve stimulation with tachycardia detection provides additional seizure reduction compared to traditional vagus nerve stimulation.
    Datta P; Galla KM; Sajja K; Wichman C; Wang H; Madhavan D
    Epilepsy Behav; 2020 Oct; 111():107280. PubMed ID: 32759064
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical outcomes of VNS therapy with AspireSR
    Hamilton P; Soryal I; Dhahri P; Wimalachandra W; Leat A; Hughes D; Toghill N; Hodson J; Sawlani V; Hayton T; Samarasekera S; Bagary M; McCorry D; Chelvarajah R
    Seizure; 2018 May; 58():120-126. PubMed ID: 29702409
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A prospective, multicenter study of cardiac-based seizure detection to activate vagus nerve stimulation.
    Boon P; Vonck K; van Rijckevorsel K; El Tahry R; Elger CE; Mullatti N; Schulze-Bonhage A; Wagner L; Diehl B; Hamer H; Reuber M; Kostov H; Legros B; Noachtar S; Weber YG; Coenen VA; Rooijakkers H; Schijns OE; Selway R; Van Roost D; Eggleston KS; Van Grunderbeek W; Jayewardene AK; McGuire RM
    Seizure; 2015 Nov; 32():52-61. PubMed ID: 26552564
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Implantation of a new Vagus Nerve Stimulation (VNS) Therapy® generator, AspireSR®: considerations and recommendations during implantation and replacement surgery--comparison to a traditional system.
    Schneider UC; Bohlmann K; Vajkoczy P; Straub HB
    Acta Neurochir (Wien); 2015 Apr; 157(4):721-8. PubMed ID: 25673257
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical outcomes of closed-loop vagal nerve stimulation in patients with refractory epilepsy.
    Tzadok M; Harush A; Nissenkorn A; Zauberman Y; Feldman Z; Ben-Zeev B
    Seizure; 2019 Oct; 71():140-144. PubMed ID: 31326720
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Additional seizure reduction by replacement with Vagus Nerve Stimulation Model 106 (AspireSR).
    Kawaji H; Yamamoto T; Fujimoto A; Uchida D; Ichikawa N; Yamazoe T; Okanishi T; Sato K; Nishimura M; Tanaka T; Namba H
    Neurosci Lett; 2020 Jan; 716():134636. PubMed ID: 31751671
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Automatic Vagus Nerve Stimulation Triggered by Ictal Tachycardia: Clinical Outcomes and Device Performance--The U.S. E-37 Trial.
    Fisher RS; Afra P; Macken M; Minecan DN; Bagić A; Benbadis SR; Helmers SL; Sinha SR; Slater J; Treiman D; Begnaud J; Raman P; Najimipour B
    Neuromodulation; 2016 Feb; 19(2):188-95. PubMed ID: 26663671
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of utilization and cost of healthcare services and pharmacotherapy following implantation of vagus nerve stimulation
    Vincent T; Li Q; Zhang L; Stokes M; Danielson V; Murphy J; Barion F; Lam S; Lassagne R; Berger A
    J Med Econ; 2022; 25(1):1218-1230. PubMed ID: 36384429
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Frequency of Automatic Stimulations in Responsive Vagal Nerve Stimulation in Patients With Refractory Epilepsy.
    Kulju T; Haapasalo J; Verner R; Dibué-Adjei M; Lehtimäki K; Rainesalo S; Peltola J
    Neuromodulation; 2020 Aug; 23(6):852-858. PubMed ID: 32840019
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An economic evaluation of vagus nerve stimulation as an adjunctive treatment to anti-seizure medications for the treatment of drug resistant epilepsy in the United States.
    Raspin C; Faught E; Armand J; Barion F; Pollit V; Murphy J; Danielson V
    J Med Econ; 2023; 26(1):189-199. PubMed ID: 36691763
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluating vagus nerve stimulation treatment with heart rate monitoring in pediatric patients with intractable epilepsy.
    Santhumayor B; Karkare S; Kothare S; Rodgers S
    Childs Nerv Syst; 2022 Mar; 38(3):547-556. PubMed ID: 34837500
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of Cardiac-Based Vagus Nerve Stimulation Closed-Loop Stimulation on the Seizure Outcome of Patients With Generalized Epilepsy: A Prospective, Individual-Control Study.
    Cukiert A; Cukiert CM; Mariani PP; Burattini JA
    Neuromodulation; 2021 Aug; 24(6):1018-1023. PubMed ID: 33047437
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety of vagus nerve stimulation and responsive neurostimulation used in combination for multifocal and generalized onset epilepsy in pediatric patients.
    Beaudreault CP; Spirollari E; Naftchi AF; Sukul V; Das A; Vazquez S; Wolf SM; McGoldrick PE; Muh CR
    J Neurosurg Pediatr; 2023 Jun; 31(6):565-573. PubMed ID: 36933267
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Seizure improvement following vagus nerve stimulator (VNS) battery change with cardiac-based seizure detection automatic stimulation (AutoStim): early experience in a regional paediatric unit.
    Lo WB; Chevill B; Philip S; Agrawal S; Walsh AR
    Childs Nerv Syst; 2021 Apr; 37(4):1237-1241. PubMed ID: 33174154
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Comparison of Vagal Nerve Stimulation and Responsive Neurostimulation for the Treatment of Medically Refractory Complex Partial Epilepsy.
    Ellens NR; Elisevich K; Burdette DE; Patra SE
    Stereotact Funct Neurosurg; 2018; 96(4):259-263. PubMed ID: 30149389
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circadian distribution of autostimulations in rVNS therapy in patients with refractory focal epilepsy.
    Kulju T; Verner R; Dibué-Adjei M; Eronen A; Rainesalo S; Lehtimäki K; Haapasalo J; Peltola J
    Epilepsy Behav; 2020 Sep; 110():107144. PubMed ID: 32473521
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Economic and clinical evaluation of vagus nerve stimulation therapy.
    Kopciuch D; Barciszewska AM; Fliciński J; Paczkowska A; Winczewska-Wiktor A; Jankowski R; Steinborn B; Nowakowska E
    Acta Neurol Scand; 2019 Oct; 140(4):244-251. PubMed ID: 31165476
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Effectiveness of Vagus Nerve Stimulation in Drug-Resistant Epilepsy Correlates with Vagus Nerve Stimulation-Induced Electroencephalography Desynchronization.
    Sangare A; Marchi A; Pruvost-Robieux E; Soufflet C; Crepon B; Ramdani C; Chassoux F; Turak B; Landre E; Gavaret M
    Brain Connect; 2020 Dec; 10(10):566-577. PubMed ID: 33073582
    [No Abstract]   [Full Text] [Related]  

  • 19. Comparison of traditional and closed loop vagus nerve stimulation for treatment of pediatric drug-resistant epilepsy: A propensity-matched retrospective cohort study.
    Muthiah N; Akwayena E; Vodovotz L; Sharma N; Jeong JH; White GE; Abel TJ
    Seizure; 2022 Jan; 94():74-81. PubMed ID: 34872020
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety following two or more years of vagus nerve stimulation (VNS Therapy) in pediatric patients with drug-resistant epilepsy enrolled in a Russian VNS Registry.
    Feygina AA; Koshelyaevskaya YN; Dibué M; Voronkova KV; Klochkov MN; Koroleva NY; Ivanov SS; Bolshakova ES; Fatykhova EF
    Brain Behav; 2023 Jul; 13(7):e3076. PubMed ID: 37254623
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.